Investigating the Combination of Trastuzumab and HER2/neu Peptide Vaccines for the Treatment of Breast Cancer

Overview of attention for article published in Annals of Surgical Oncology, July 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 7 patents

Citations

dimensions_citation: 63 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

Combination immunotherapy for treatment of triple-negative breast cancer

Grant US-11564987-B2

United States of America

High affinity T cell receptor and use thereof

Grant US-10626159-B2

United States of America

High affinity T cell receptor and use thereof

Grant US-9862755-B2

United States of America

Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells

Grant US-9597384-B2

United States of America

Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells

Grant US-9238063-B2

United States of America

High affinity T cell receptor and use thereof

Grant US-8697854-B2

United States of America

NON-SELF T - CELL EPITOPE FUSED TO AN ANTIBODY THAT RECOGNISES A TUMOUR - SPECIFIC CELL -SU…

Application WO-2012136824-A1

World Intellectual Property Organisation (WIPO)